Fan Yi Meng
Overview
Explore the profile of Fan Yi Meng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu L, Zhao X, Miao F, Ghosh B, Dong L, Tao B, et al.
Opt Express
. 2019 May;
27(9):12163-12170.
PMID: 31052760
In this study, electromagnetically induced transparency (EIT) effect in all-dielectric metamaterial for dual-band linear-to-circular (LTC) polarization conversion is demonstrated numerically and experimentally. The unit cell is composed of three ceramic...
2.
Wang Q, Zhou H, Huang K, Jiang X, Wu F, Cao R, et al.
Int J Oncol
. 2011 Oct;
40(2):418-26.
PMID: 22002244
Anaphase promoting complex cofactor Cdh1 plays a critical role in tumor suppression and genomic stability in cancer. However, its role in chronic myeloid leukemia (CML) remains unclear. We treated both...
3.
Liu C, Li J, Meng F, Liang S, Deng R, Li C, et al.
BMC Complement Altern Med
. 2010 Dec;
10:79.
PMID: 21176128
Background: Dozens of Traditional Chinese Medicine (TCM) formulas have been used for promotion of "blood production" for centuries, and we are interested in developing novel thrombopoietic medicines from these TCMs....
4.
Ye J, Chan G, Qiao L, Lian Q, Meng F, Luo X, et al.
Haematologica
. 2010 Jun;
95(10):1745-53.
PMID: 20562316
Background: Platelet-derived growth factor is involved in the regulation of hematopoiesis. Imatinib mesylate, a platelet-derived growth factor receptor inhibitor, induces thrombocytopenia in a significant proportion of patients with chronic myeloid...